ArticleCureus2025
Unmasking Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE) Through Multimodal Imaging: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Acute posterior multifocal placoid pigment epitheliopathy presenting with granulomatous panuveitis.American journal of ophthalmology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a rare, immune-mediated chorioretinal inflammatory condition typically affecting healthy young adults. It often presents with acute bilateral vision loss and multiple creamy placoid lesions at the level of the retinal pigment epithelium, frequently following a flu-like or viral prodrome. We report the case of a 24-year-old male who developed bilateral subacute vision loss, three days in duration, one month after a febrile upper respiratory infection. Fundus examination revealed multiple yellow-white placoid lesions in both eyes, and multimodal retinal imaging (optical coherence tomography (OCT), fundus autofluorescence (AF), and OCT angiography (OCTA)) confirmed features consistent with APMPPE. A comprehensive infectious and autoimmune workup was negative, and neuro-imaging showed no evidence of cerebral vasculitis. The patient was managed conservatively without immunosuppressive therapy. Over the course of two weeks, his visual acuity spontaneously improved from 20/65 (logarithm of the Minimum Angle of Resolution (logMAR) = 0.5) to 20/30 (logMAR = 0.2) in the right eye and from 20/25 (logMAR = 0.1) to 20/20 (logMAR = 0) in the left eye, with corresponding regression of the retinal lesions. This case highlights the importance of recognizing APMPPE in the appropriate clinical context through non-invasive multimodal imaging, distinguishing it from infectious or chronic placoid retinopathies, emphasizing the role of careful observation and follow-up in managing this condition with a favorable visual prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.